P.134a Phase 1/2a trial of delandistrogene moxeparvovec in patients with DMD: 4-year update

Saved in:
Bibliographic Details
Published in:Neuromuscular disorders : NMD 2022-10, Vol.32, p.S102-S103
Main Authors: Mendell, J., Sahenk, Z., Lehman, K., Lowes, L., Reash, N., Iammarino, M., Alfano, L., Lewis, S., Church, K., Shell, R., Potter, R., Griffin, D., Pozsgai, E., Hogan, M., Hu, L., Mason, S., Darton, E., Rodino-Klapac, L.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0960-8966
DOI:10.1016/j.nmd.2022.07.251